PHARMANAL
LIVE

Serial Number

79448032

Owner

Pharmanal B.V.

Filing Date

Jan 14, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PHARMANAL Trademark

Serial Number: 79448032

PHARMANAL is a trademark filed by Pharmanal B.V. on January 14, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Pharmanal B.V.

Edisonstraat 22C

Entity Type: 98

Trademark Details

Filing Date

January 14, 2026

Registration Date

Not Registered

Goods & Services

Dietary supplements and dietetic preparations; food supplements; dietary supplements in solid form, food supplements in liquid form, food supplements in powdered form or dietary supplements in dissolved form; vitamin and mineral supplements.

Advertising, marketing and promotional services; dissemination of advertising and promotional materials; sales promotion; business management; business administration; office functions; commercial intermediation services; wholesale and retail services for goods, also via an online shop, in relation to the following goods: dietary supplement product and dietetic preparations, supplements for food, dietary supplements in solid form, food supplements in liquid form, food supplement preparations in powdered form or dietary supplements in dissolved form, vitamin and mineral supplements; collecting and systematising data in a database in relation to fulfilling orders for others; administrative processing of computerized purchase orders; information and consultancy relating to the aforesaid services, also via electronic networks, such as the internet, via internet platforms or via social media.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 16, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 15, 2026 CNRT
ASSIGNED TO EXAMINER
May 12, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 16, 2026 REPR